NCT05875987View on ClinicalTrials.gov

Evaluation of the Quantra QStat System in Obstetric Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

May 10, 2024

Conditions
Blood Loss MassivePost Operative Hemorrhage
Interventions
DEVICE

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Trial Locations (1)

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

HemoSonics LLC
All Listed Sponsors
lead

HemoSonics LLC

INDUSTRY

NCT05875987 - Evaluation of the Quantra QStat System in Obstetric Patients | Biotech Hunter | Biotech Hunter